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Abstract 15 
An unusual increase of Campylobacter concisus in stool cultures provoked an outbreak 16 
investigation at the University Hospital of Bern. No epidemiological links were found 17 
between cases, and the Campylobacter isolates were clonally unrelated. A change in 18 
culture conditions to a hydrogen-rich atmosphere enhancing growth of C. concisus was 19 
deemed responsible for this pseudo-outbreak. 20 
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Text 25 
Campylobacter concisus is a fastidious Campylobacter species whose pathogenic role in 26 
human disease is not established. Isolation of C. concisus in respective samples has been 27 
reported in periodontal disease, Barrett’s esophagus (1, 2), enteritis, and inflammatory 28 
bowel disease (IBD) (3), and the pathogen has been proposed to be linked to certain 29 
hepatobiliary and kidney conditions in children (4). High prevalences of C. concisus in 30 
stool samples were not only encountered in children and adults suffering from diarrhea 31 
(detection rate: 0.7- 49%) but also in healthy controls (detection rate: 0-52%) (1, 3). 32 
Immunodeficiency (5) and age extremes (6, 7) appear to be determinants of higher 33 
prevalence in stool. Moreover, C. concisus could be detected by PCR almost universally 34 
in human saliva samples (3). Thus it is unresolved whether C. concisus is merely a 35 
commensal of the human digestive tract or a true pathogen. In light of its genetic 36 
variability both may be true (1, 2). In late 2013, a substantial increase in the number of 37 
stool cultures positive for C. concisus was observed at the Bern University Hospital.  In 38 
order to rule out an outbreak, an epidemiological investigation was conducted. 39 
 40 
Bern University Hospital is a 950-bed tertiary care teaching hospital in 41 
Switzerland. In the microbiology laboratory, approximately 2,000 stool samples are 42 
cultured for enteropathogenic bacteria each year. For Campylobacter cultures, clinical 43 
stool specimens were inoculated onto Preston agar plates and incubated in a microaerobic 44 
atmosphere at 35°C and 42°C, respectively, for 48 hours. Microaerobic conditions were 45 
obtained with gas generator packs (CampyGen, Oxoid, UK) producing a final atmosphere 46 
of 5% O2, 10% CO2 and 85% N2, or with evacuation and gas replacement of anaerobic 47 
jars (TRILAB, Jenny Science, Switzerland) containing approximately 5% O2, 8% CO2, 48 
15% H2 and 72% N2 (replacing 76% of the air with an anaerobic gas mixture containing 49 
70% N2, 20% H2 and 10% CO2). Isolates were identified by matrix-assisted laser 50 
3 
 
desorption/ionization time-of-flight mass spectrometry (Bruker Biotyper MALDI-51 
TOF/MS, Bruker Daltonics, Bremen, Germany) and sequence analysis using the 52 
MicroSeq®500 16S rDNA PCR and Sequencing Kits (Applied Biosystems, Foster City, 53 
CA). Genetic relatedness of isolates was analyzed by repetitive extragenic palindromic 54 
PCR (rep-PCR) (8). Cases were defined as all patients with C. concisus isolated from 55 
stool samples between 2003 and 2013. Retrospective and prospective case finding was 56 
performed including patients meeting the case definition during 2013. Incidence data 57 
were taken from electronic data on all samples processed at the microbiology laboratory. 58 
The laboratory incidence was defined as number of C. concisus identifications divided by 59 
the total number of stool cultures processed in the given time period. Epidemiological and 60 
clinical data were taken from the hospital’s electronic patient chart (CGM Phoenix, 61 
Parametrix Solution, Lachen, Switzerland), primarily focusing on acquisition mode 62 
(nosocomial vs. community-acquired). Nosocomial acquisition was defined as diagnosis 63 
>48 hours after hospital admission. Patients diagnosed as outpatients with hospitalization 64 
within the previous month were considered to have nosocomial C. concisus (3, 9). This 65 
outbreak investigation was part of the infection prevention mandate and therefore not 66 
subject to review by the ethics committee.  67 
(This work was partially presented as a poster at the 24th ECCMID 2014 in Barcelona, 68 
Spain.) 69 
 70 
In the decade prior to the increase C. concisus was rarely detected in routine stool 71 
cultures (on average 1.1 isolates annually). In 2013 C. concisus was isolated from stool 72 
specimens of 21 individual patients and from an intestinal biopsy of another patient. In all 73 
instances, C. concisus was the sole organism with pathogenic potential detected. The 74 
incidence increased from an average of 0.03 % (1/2012- 5/2013) to 1.92% (June-75 
December 2013); p<0.001, chi-square test (Fig. 1). 76 
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Mean age of the 22 patients included in the analysis was 46.7 years (SD±25.9 years, 77 
range: 3 months-85 years). Eleven of 22 patients were female. Eight of 22 patients were 78 
outpatients. In 8/14 inpatients C. concisus was detected >48 hours after the first 79 
admission and in 3/14 patients more than 48 hours into the admission, during which the 80 
diagnosis was made. Two patients (#3 and #5) were hospitalized on the same ward during 81 
the same time period prior to C. concisus detection, with patient #3 being on contact 82 
precautions due to diarrhea of unknown etiology. Prior to detection of C. concisus, 3/22 83 
patients had colonoscopy at our hospital and 1/22 at an external hospital (with intervals of 84 
1, 4, 122, and 140 days prior to diagnosis). Two patients had colonoscopy on the same 85 
ward but months apart. In one additional patient, C. concisus was cultured from biopsy 86 
material. Putative risk factors for colonization/infection were found in 13/22 patients 87 
[immunodeficiency=6 (3 with IBD); extremes of age=6; extremes of age and 88 
immunodeficiency=1]. Seven of 22 cases suffered from either IBD (n=4) or chronic 89 
kidney disease (n=3), among which 4/7 cases were also immunodeficient.  Fig. 2 90 
summarizes epidemiological data and the results of rep-PCR-based genotyping. 91 
After reviewing the cases, a change in microaerobic culture conditions was identified as 92 
the most likely explanation for the putative outbreak. Shortly before the C. concisus 93 
incidence started to increase, an automated system for the evacuation and gas replacement 94 
of anaerobic jars had been introduced. In contrast to the previously used microaerobic gas 95 
generator packs, which do not produce hydrogen, the resulting atmosphere of the new 96 
system contained approximately 15% hydrogen. Some Campylobacter species, such as C. 97 
concisus, appear to require increased hydrogen concentrations for optimal growth (10). 98 
When subculturing five frozen C. concisus isolates (not the original stool samples) from 99 
the study period under both culture conditions, only weak or no growth was encountered 100 
with the previous methodology (Fig. 3).  101 
In conclusion, a pseudo-outbreak of C. concisus due to a change in laboratory procedures 102 
was identified. A pseudo-outbreak is defined as an episode of increased disease incidence 103 
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due to enhanced surveillance or other factors but not related to the disease under study 104 
(11).  Except for one patient, no epidemiological links suggesting nosocomial 105 
transmission were found. In addition, genotyping revealed no close relationship between 106 
the isolates available for testing. Unfortunately, the isolate of the first – and potential 107 
index - case (#3) was not available for genotyping. The introduction of a new 108 
microaerobic culture system containing a high hydrogen concentration compared to 109 
conventional microaerobic conditions presumably led to a better recovery of C. concisus 110 
from fecal samples. The clinical significance of C. concisus remains unclear to date but 111 
may be easier to determine as diagnostic procedures improve and permit the 112 
differentiation between pathogenic and non-pathogenic strains. 113 
 114 
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Figure legends 127 
 128 
Figure 1: (A) Annual number of clinical samples and patients positive for C. concisus 129 
from 2003 to 2013. (B) Absolute numbers (squares) and incidence (solid line) of C. 130 
concisus isolates from January 2012 to December 2013. The arrow indicates the 131 
introduction of the new culture method.  132 
 133 
Figure 2: Results of genotyping and epidemiologic data of all 22 patients diagnosed with 134 
C. concisus in stool samples taken in 2013. One strain was isolated from an intestinal 135 
biopsy (patient #17). Patients are numbered in the order of collected culture. A strain (X) 136 
isolated in 2010 was included as unrelated control for typing purposes. NA, not available; 137 
m, male; f, female 138 
 139 
Figure 3: C. concisus isolate subcultured under previous (A, gas generator pack, only few 140 
pinpoint colonies visible (arrow)) and new culture conditions (B, anaerobic jar 141 
supplemented with hydrogen) for 3 days at 42°C.  142 
  143 
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